Cintrifuse

Cintrifuse is a Cincinnati-based organization established in 2012 that focuses on fostering high-growth startups by connecting entrepreneurs with essential resources, including strategic businesses, research institutions, mentors, and investors. It aims to enhance the region’s innovation ecosystem by coordinating activities and resources among incubators, accelerators, and investment sources to facilitate information sharing. Cintrifuse operates as a fund of funds manager, investing in technology-related startups across the United States. By leveraging its core elements of access, place, and funding, Cintrifuse strives to cultivate a sustainable innovation economy in Ohio and beyond.

Sarah Adams Anderson

Fund Manager

Pete Blackshaw

Chief Executive Officer

Francisco Gomez

Syndicate Fund Associate

Eric Weissman

Director of Marketing

Past deals in Ohio

Enable Injections

Series C in 2022
Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.

Struxtion

Seed Round in 2021
Struxtion provides undeserved commercial construction contractors.

Enable Injections

Series B in 2018
Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.

Enable Injections

Series A in 2016
Enable Injections, LLC develops a disposable body-worn bolus injector to deliver high viscosity/volume payloads to the subcutaneous tissue. The company’s system uses standard vial, syringe, or cartridge container closure; and automatically mixes lyophilized solutions. Its drug delivery system’s transfer package automatically warms the drug, and enables user to insert the container into the system, place the injector on the skin, and press the central button, as well as know the progress of the delivery through its viewing window, and then dispose the device. It also offers partial or multi-vial/syringe transfer systems for filling its LVWIs. The company was founded in 2010 and is based in Cincinnati, Ohio.